87

Hematology&Oncology
Sub Categories on Hematology&Oncology
Latest Articles
Prior authorization delays lead to serious harm for people with cancer, nationwide survey finds

Prior authorization delays lead to serious harm for people with cancer, nationwide survey finds

byAmerican Society for Radiation OncologyCredit: American Society for Radiation OncologyA new nationwide survey of more than 750 radiation oncologists confirms that prior authorization harms peo

Prior authorization delays lead to serious harm for people with cancer, nationwide survey finds

byAmerican Society for Radiation OncologyCredit: American Society for Radiation OncologyA new nationwide survey of more than 750 radiation oncologists confirms that prior authorization harms peo
Computational model for drug resistance assessment can improve treatment for leukemia and lung cancer

Computational model for drug resistance assessment can improve treatment for leukemia and lung cancer

byLinnaeus UniversityCredit: Unsplash/CC0 Public DomainA new method can improve treatment for patients with chronic myeloid leukemia by predicting which medication will be most effective. The me

Computational model for drug resistance assessment can improve treatment for leukemia and lung cancer

byLinnaeus UniversityCredit: Unsplash/CC0 Public DomainA new method can improve treatment for patients with chronic myeloid leukemia by predicting which medication will be most effective. The me
PIVKA-II-based model IDs liver cancer risk in hep C-related cirrhosis

PIVKA-II-based model IDs liver cancer risk in hep C-related cirrhosis

by Elana GotkineAmong patients with hepatitis C virus (HCV)-related cirrhosis with sustained virological response (SVR) to direct-acting antivirals (DAAs), a serum protein induced by vitamin K absence

PIVKA-II-based model IDs liver cancer risk in hep C-related cirrhosis

by Elana GotkineAmong patients with hepatitis C virus (HCV)-related cirrhosis with sustained virological response (SVR) to direct-acting antivirals (DAAs), a serum protein induced by vitamin K absence
Low-dose plasma treatment shows promise for slowing down tumor growth

Low-dose plasma treatment shows promise for slowing down tumor growth

by Nie Lili and Zhao Weiwei,Chinese Academy of SciencesUnder the influence of electrodes, low-temperature plasma emits a purple glow in the laboratory. Credit: Nie LiliA recent study has shown t

Low-dose plasma treatment shows promise for slowing down tumor growth

by Nie Lili and Zhao Weiwei,Chinese Academy of SciencesUnder the influence of electrodes, low-temperature plasma emits a purple glow in the laboratory. Credit: Nie LiliA recent study has shown t
How breast cancer cells survive in bone marrow after remission

How breast cancer cells survive in bone marrow after remission

byUniversity of MichiganGraphical abstract. Credit:Journal of Clinical Investigation(2024). DOI: 10.1172/JCI170953A study from researchers at the University of Michigan and the Unive

How breast cancer cells survive in bone marrow after remission

byUniversity of MichiganGraphical abstract. Credit:Journal of Clinical Investigation(2024). DOI: 10.1172/JCI170953A study from researchers at the University of Michigan and the Unive
Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patientsby NRG OncologyCredit: Pixabay/CC0 Public DomainRecent results from the Phase III NRG-RT

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patientsby NRG OncologyCredit: Pixabay/CC0 Public DomainRecent results from the Phase III NRG-RT
Engineered CAR-NK cells offer an alternative approach to fighting leukemia

Engineered CAR-NK cells offer an alternative approach to fighting leukemia

Engineered CAR-NK cells offer an alternative approach to fighting leukemiaby Markus Bernards,Goethe University Frankfurt am MainGeneration process and evaluation of CRISPR/Cas9 knockout for CAR3

Engineered CAR-NK cells offer an alternative approach to fighting leukemia

Engineered CAR-NK cells offer an alternative approach to fighting leukemiaby Markus Bernards,Goethe University Frankfurt am MainGeneration process and evaluation of CRISPR/Cas9 knockout for CAR3
Researchers explore e-bikes for cancer recovery

Researchers explore e-bikes for cancer recovery

by Patty Wellborn,University of British ColumbiaOutline of the CRANK intervention development. APEASE: Acceptability, Practicability, Effectiveness, Affordability, Side-Effects, and Equity; BCT:

Researchers explore e-bikes for cancer recovery

by Patty Wellborn,University of British ColumbiaOutline of the CRANK intervention development. APEASE: Acceptability, Practicability, Effectiveness, Affordability, Side-Effects, and Equity; BCT: